Search

Your search keyword '"Metastasis -- Prognosis -- Development and progression -- Drug therapy"' showing total 6 results
Start Over Descriptor "Metastasis -- Prognosis -- Development and progression -- Drug therapy"
6 results on '"Metastasis -- Prognosis -- Development and progression -- Drug therapy"'

1. BioNTech and DualityBio Issues FDA Fast Track Designation for Antibody-Drug Conjugate

Subjects
United States. Food and Drug Administration, BioNTech SE, Medical research, Medicine, Experimental, Biopharmaceutics, Prostate cancer -- Development and progression -- Prognosis -- Drug therapy, Metastasis -- Prognosis -- Development and progression -- Drug therapy, Biotechnology industry, Viral antibodies, Antibodies, General interest, News, opinion and commentary
Abstract

MAINZ: BioNTech SE and Duality Biologics Co., Ltd. announced that the U.S. Food and Drug Administration granted Fast Track designation for BNT324/DB-1311 for the treatment of patients with advanced/unresectable, or [...]

Published
2024

2. Prolonged response to Tyrosine Kinase Inhibitors followed by Immunotherapy in metastatic hepatocellular carcinoma: A rare case report

Author

Roy, Parag and Parthasarathy, K.

Subjects
Tyrosine, Metastasis -- Prognosis -- Development and progression -- Drug therapy, Hepatitis C virus, Immunotherapy, Hepatoma -- Development and progression -- Prognosis -- Drug therapy, Health
Abstract

Byline: Parag. Roy, K. Parthasarathy The overall prognosis of hepatocellular carcinoma (HCC) is dismal and 5-year survival rate is 14.8%. We report a case of HCC coinfected with hepatitis C [...]

Published
2023

3. Researchers' Work from Institute of Biology & Experimental Medicine Focuses on Breast Cancer (New Insights In the Interaction of Fgf/fgfr and Steroid Receptor Signaling In Breast Cancer)

Subjects
Oncology, Experimental, Women -- Health aspects, Metastasis -- Prognosis -- Development and progression -- Drug therapy, Breast cancer -- Prognosis -- Development and progression -- Drug therapy, Cancer -- Research, Health, Women's issues/gender studies
Abstract

2022 MAR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators discuss new findings in Oncology - Breast Cancer. According to news reporting from [...]

Published
2022

4. Japan : ENHERTU Supplemental New Drug Application Submitted in Japan for Patients with HER2 Mutant Metastatic Non-Small Cell Lung Cancer

Subjects
Metastasis -- Prognosis -- Development and progression -- Drug therapy, Lung cancer, Small cell -- Development and progression -- Prognosis -- Drug therapy, Lung cancer, Non-small cell -- Development and progression -- Prognosis -- Drug therapy, Business, international, Enhertu (Medication)
Abstract

Daiichi Sankyo announced that it has submitted a supplemental New Drug Application (sNDA) to Japans Ministry of Health, Labour and Welfare (MHLW) for ENHERTU (trastuzumab deruxtecan) for the treatment of [...]

Published
2022

5. Data on Urothelial Cancer Reported by Researchers at Ministry of Health (Precision Medicine in the Treatment of Locally Advanced or Metastatic Urothelial Cancer: New Molecular Targets and Pharmacological Therapies)

Subjects
Oncology, Experimental, Metastasis -- Prognosis -- Development and progression -- Drug therapy, Immunotherapy, Cancer -- Prognosis -- Development and progression -- Drug therapy -- Research, Health
Abstract

2022 NOV 9 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators discuss new findings in urothelial cancer. According to news reporting from Rome, Italy, by [...]

Published
2022

6. Study Findings on Disease Progression Published by Researchers at N.N. Petrov National Medical Research Center of Oncology (The Importance of Circulating Tumor Dna in The Assessment of Metastatic Colorectal Cancer Treatment Effectivne)

Subjects
Oncology, Experimental -- Analysis, DNA -- Analysis, Metastasis -- Prognosis -- Development and progression -- Drug therapy, Colorectal cancer -- Development and progression -- Prognosis -- Drug therapy, Cancer -- Care and treatment -- Genetic aspects -- Research, Panitumumab -- Analysis, Biological markers -- Analysis, Business, Health, Health care industry
Abstract

2022 FEB 15 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on disease progression have been published. According to news reporting out of [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results